Skip to main content

FDA approves Aurobindo's olopatadine hydrochloride solution

12/22/2015

DAYTON, N.J. — Aurbindo on Monday announced that it has received approval from the Food and Drug Administration for its olopatadine hydrochloride ophthalmic solution USP, 0.1%, a bioequivalent version of Alcon's Patanol.


Olopatadine hydrochloride ophthalmic solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis.


The solution had sales of $234.5 million for the twelve months ended October 2015, according to IMS.


X
This ad will auto-close in 10 seconds